An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 217884
Company: FRESENIUS KABI USA

Products on ANDA 217884

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
SUCCINYLCHOLINE CHLORIDE	SUCCINYLCHOLINE CHLORIDE	100MG/5ML (20MG/ML)	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	Prescription	AP	No	Yes

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 217884

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
02/11/2025	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 217884

SUCCINYLCHOLINE CHLORIDE

SOLUTION;INTRAMUSCULAR, INTRAVENOUS; 100MG/5ML (20MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
SUCCINYLCHOLINE CHLORIDE	SUCCINYLCHOLINE CHLORIDE	100MG/5ML (20MG/ML)	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	Prescription	No	AP	218467	DR REDDYS
SUCCINYLCHOLINE CHLORIDE	SUCCINYLCHOLINE CHLORIDE	100MG/5ML (20MG/ML)	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	Prescription	No	AP	217884	FRESENIUS KABI USA
SUCCINYLCHOLINE CHLORIDE	SUCCINYLCHOLINE CHLORIDE	100MG/5ML (20MG/ML)	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	Prescription	No	AP	217873	STERISCIENCE

Top